Stocks
Humana Financial Statements (HUM) |
||||||||||
| Humanasmart-lab.ru | % | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 26.04.2023 | 02.08.2023 | 01.11.2023 | 15.02.2024 | 24.04.2024 | 24.04.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 26 742 | 26 747 | 26 423 | 26 462 | 29 611 | 109 243 | |||
| Operating Income, bln rub | 1 679 | 1 436 | 1 206 | -308.0 | 1 236 | 3 570 | ||||
| EBITDA, bln rub | ? | 1 897 | 1 566 | 1 403 | -301.0 | 1 360 | 4 028 | |||
| Net profit, bln rub | ? | 1 239 | 959.0 | 832.0 | -541.0 | 741.0 | 1 991 | |||
| OCF, bln rub | ? | 6 687 | 3 176 | 1 252 | -7 134 | 423.0 | -2 283 | |||
| CAPEX, bln rub | ? | 223.0 | 264.0 | 234.0 | 283.0 | 177.0 | 958.0 | |||
| FCF, bln rub | ? | 6 464 | 2 912 | 1 018 | -7 417 | 246.0 | -3 241 | |||
| Dividend payout, bln rub | 100.0 | 111.0 | 109.0 | 111.0 | 109.0 | 440.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 8.07% | 11.6% | 13.1% | 0.00% | 14.7% | 22.1% | ||||
| OPEX, bln rub | 25 023 | 25 311 | 25 217 | 4 025 | 3 251 | 57 804 | ||||
| Cost of production, bln rub | 2 979 | 3 111 | 3 271 | 3 827 | 3 042 | 13 251 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 113.0 | 120.0 | 114.0 | 146.0 | 159.0 | 539.0 | ||||
| Assets, bln rub | 54 776 | 56 455 | 55 905 | 46 892 | 50 091 | 50 091 | ||||
| Net Assets, bln rub | ? | 16 577 | 16 834 | 16 949 | 16 262 | 16 130 | 16 130 | |||
| Debt, bln rub | 12 016 | 12 201 | 11 974 | 12 269 | 13 212 | 13 212 | ||||
| Cash, bln rub | 28 667 | 31 465 | 30 293 | 21 320 | 22 607 | 22 607 | ||||
| Net debt, bln rub | -16 651 | -19 264 | -18 319 | -9 051 | -9 395 | -9 395 | ||||
| Ordinary share price, rub | 485.5 | 447.1 | 486.5 | 457.8 | 346.7 | 481.1 | ||||
| Number of ordinary shares, mln | 125.0 | 124.6 | 123.4 | 122.5 | 121.0 | 121.0 | ||||
| Market cap, bln rub | 60 685 | 55 701 | 60 049 | 56 064 | 41 945 | 58 201 | ||||
| EV, bln rub | ? | 44 034 | 36 437 | 41 730 | 47 013 | 32 550 | 48 806 | |||
| Book value, bln rub | 5 503 | 5 513 | 5 644 | 5 019 | 4 888 | 4 888 | ||||
| EPS, rub | ? | 9.91 | 7.70 | 6.74 | -4.42 | 6.13 | 16.5 | |||
| FCF/share, rub | 51.7 | 23.4 | 8.25 | -60.6 | 2.03 | -26.8 | ||||
| BV/share, rub | 44.0 | 44.3 | 45.7 | 41.0 | 40.4 | 40.4 | ||||
| EBITDA margin, % | ? | 7.09% | 5.85% | 5.31% | -1.14% | 4.59% | 3.69% | |||
| Net margin, % | ? | 4.63% | 3.59% | 3.15% | -2.04% | 2.50% | 1.82% | |||
| FCF yield, % | ? | 16.4% | 21.8% | 8.34% | 5.31% | -7.73% | -5.57% | |||
| ROE, % | ? | 18.8% | 20.1% | 17.8% | 15.3% | 12.3% | 12.3% | |||
| ROA, % | ? | 5.69% | 5.99% | 5.40% | 5.31% | 3.97% | 3.97% | |||
| P/E | ? | 19.5 | 16.5 | 19.9 | 22.5 | 21.1 | 29.2 | |||
| P/FCF | 6.11 | 4.58 | 12.0 | 18.8 | -12.9 | -18.0 | ||||
| P/S | ? | 0.63 | 0.56 | 0.59 | 0.53 | 0.38 | 0.53 | |||
| P/BV | ? | 11.0 | 10.1 | 10.6 | 11.2 | 8.58 | 11.9 | |||
| EV/EBITDA | ? | 8.47 | 6.83 | 8.15 | 10.3 | 8.08 | 12.1 | |||
| Debt/EBITDA | -3.20 | -3.61 | -3.58 | -1.98 | -2.33 | -2.33 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 0.83% | 0.99% | 0.89% | 1.07% | 0.60% | 0.88% | ||||
| Humana shareholders | ||||||||||
